Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Oct;103(10):1919-1932.
doi: 10.1111/aogs.14858. Epub 2024 Jul 3.

Optimizing intrauterine insemination: A systematic review and meta-analysis of the effectiveness and safety of clinical treatment add-ons

Affiliations
Meta-Analysis

Optimizing intrauterine insemination: A systematic review and meta-analysis of the effectiveness and safety of clinical treatment add-ons

Elpiniki Chronopoulou et al. Acta Obstet Gynecol Scand. 2024 Oct.

Abstract

Introduction: Intrauterine insemination (IUI) is one of the most widespread fertility treatments. However, IUI protocols vary significantly amongst fertility clinics. Various add-on interventions have been proposed to boost success rates. These are mostly chosen arbitrarily or empirically. The aim of this systematic review and meta-analysis is to assess the effectiveness and safety of add-on interventions to the standard IUI protocol and to provide evidence-based recommendations on techniques used to optimize the clinical outcomes of IUI treatment.

Material and methods: Systematic review and meta-analyses were performed in accordance with PRISMA guidelines. A computerized literature search was performed from database inception to May 2023. Randomized controlled trials (RCTs) were included reporting on couples/single women undergoing IUI with any protocol for any indication using partner's or donor sperm. A meta-analysis based on random effects was performed for each outcome and add-on. Three authors independently assessed the trials for quality and risk of bias and overall certainty of evidence. Uncertainties were resolved through consensus. Primary outcomes were ongoing pregnancy rate (OPR) or live birth rate (LBR) per cycle/per woman randomized. Registration number PROSPERO: CRD42022300857.

Results: Sixty-six RCTs were included in the analysis (16 305 participants across 20 countries). Vaginal progesterone as luteal phase support in stimulated cycles was found to significantly increase LBR/OPR (RR 1.37, 95% CI 1.09-1.72, I2 = 4.9%) (moderate/low certainty of the evidence). Endometrial scratch prior/during stimulated IUI cycles may increase LBR/OPR (RR 1.44, 95% CI 1.03-2.01, I2 = 1.8%), but evidence is very uncertain. Results from two studies suggest that follicular phase ovarian stimulation increases LBR/OPR (RR 1.39, 95% CI 1.00-1.94, I2 = 0%) (low certainty of evidence). No significant difference was seen for the primary outcome for the other studied interventions.

Conclusions: The findings of this systematic review and meta-analysis suggest that vaginal luteal phase progesterone support probably improves LBR/OPR in stimulated IUI treatments. In view of moderate/low certainty of the evidence more research is needed for solid conclusions. Further research is also recommended for the use of endometrial scratch and ovarian stimulation. Future studies should report on results according to subfertility background as it is possible that different add-ons could benefit specific patient groups.

Keywords: IUI; add‐ons; bed rest; insemination; progesterone; scratch.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare that are relevant to the content of this article.

Figures

FIGURE 1
FIGURE 1
Selection and inclusion process for randomized controlled trials evaluating add‐on interventions in women undergoing intrauterine insemination cycles. From Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.
FIGURE 2
FIGURE 2
Summary forest plot of effect estimates of evaluated interventions before during or after intrauterine insemination on live birth rate/ongoing pregnancy rate.
FIGURE 3
FIGURE 3
Study estimates of the comparison of the add‐on endometrial scratch on the outcome live birth or ongoing pregnancy, clinical pregnancy, biochemical pregnancy, miscarriages, and multiple pregnancies. Predicted intervals are only calculated when more than two studies were included in the analysis.
FIGURE 4
FIGURE 4
Study estimates of the comparison of the add‐on luteal phase on the outcome live birth or ongoing pregnancy, clinical pregnancy, biochemical pregnancy, miscarriages, and multiple pregnancies.

Similar articles

References

    1. Cohen MR. Intrauterine insemination. Int J Fertil. 1962;7:235‐240. - PubMed
    1. Starosta A, Gordon CE, Hornstein MD. Predictive factors for intrauterine insemination outcomes: a review. Fertil Res Pract. 2020;6:23. - PMC - PubMed
    1. Calhaz‐Jorge C, de Geyter C, Kupka MS, et al. Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017;32:1957‐1973. - PubMed
    1. Osuna C, Matorras R, Rodriguez‐Escudero FJ, Pijoan JI. The heterogeneity of randomized, controlled trials of intrauterine insemination. Fertil Steril. 2004;82:34‐35. - PubMed
    1. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. - PMC - PubMed

LinkOut - more resources